Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...
Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...
Implementing the ventilator-associated events (VAE) prevention protocol at Community Health Network has yielded remarkable ...
Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...
The drug’s developer, Cereno Scientific, believes its oral therapy could have a major impact on the pulmonary arterial ...
Cash, cash equivalents and marketable securities as of December 31, 2024, were $294.5 million. As a result, we expect our ...
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
The following is a summary of "Association of insulin resistance surrogates with disease severity and adverse outcomes in chronic thromboembolic pulmonary hypertension: a multicenter cohort study," ...
Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback